Cost Curve News - News - https://www.costcurvenews.com/blog/page/4/

Health Spending Is Only Headed in One Direction — Up — and Employers Are Blaming the Meds

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

The Three (Generally Ignored) Forces Driving the Pharm-to-Table Trend

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

Hardly Anyone Is Using the Medicare Prescription Payment Plan

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

Lilly Takes a First Step in ‘Rebalancing’ U.S. and International Prices

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

The White House View on Pharm-to-Table: ‘It’s Not the Solution in Itself’

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

Three New Drugs, Three Prices, Three Disclosure Approaches

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

A Big Study Found that Semaglutide Users Saw Increased Health Spending. Should We Be Surprised?

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

How MFN Raises the Possibility of a ‘Worst of Both Worlds’ Approach to International Drug Pricing

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

Boehringer Ingelheim’s Appeal to Overturn the IRA on Constitutional Grounds is Dismissed

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Cost Curve News

Action On IRA Lawsuits: Appeals Court Rejects the U.S. Chamber Effort on Technical Grounds

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

2 months ago

Keep Reading

Health Spending Is Only Headed in One Direction — Up — and Employers Are Blaming the Meds

The Three (Generally Ignored) Forces Driving the Pharm-to-Table Trend

Hardly Anyone Is Using the Medicare Prescription Payment Plan

Lilly Takes a First Step in ‘Rebalancing’ U.S. and International Prices

The White House View on Pharm-to-Table: ‘It’s Not the Solution in Itself’

Three New Drugs, Three Prices, Three Disclosure Approaches

A Big Study Found that Semaglutide Users Saw Increased Health Spending. Should We Be Surprised?

How MFN Raises the Possibility of a ‘Worst of Both Worlds’ Approach to International Drug Pricing

Boehringer Ingelheim’s Appeal to Overturn the IRA on Constitutional Grounds is Dismissed

Action On IRA Lawsuits: Appeals Court Rejects the U.S. Chamber Effort on Technical Grounds

Latest Posts

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Popular

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Tariffs and MFN Dominate the Headlines, But Details Remain Scant

Latest News

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

Subcribe To Newsletter